Eric G. Meissner - Concepedia

Author

Eric G. Meissner

Medical University of South Carolina ORCID

Also Known As

Coffield, Vernon M., D'Agostin, Rhiannon, Duus, Karen M., E Meissner, E. G. Meissner, E. Meissner, E.G. Meissner, Eric G Meissner, Eric G. Meissner, Eric Meissner

118

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Medical University of South Carolina National Institute of Allergy and Infectious Diseases National Institutes of Health Gilead Sciences (United States)National Institutes of Health Clinical Center

About

Eric G. Meissner is an author at Medical University of South Carolina specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	540
2	Public Health	3	3	70
3	Cell Biology	2	2	46
4	Natural Sciences	1	1	35
5	Allergy	1	1	33

Eric G. Meissner

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics A. Osinusi, Eric G. Meissner, Y.-J. Lee, JAMA	2013	285
Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection Anu Osinusi, Kerry Townsend, Anita Kohli, JAMA	2015	203
Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome Eric G. Meissner, David Wu, Anu Osinusi, Journal of Clinical Investigation	2014	200
Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients Eric G. Meissner, Y.-J. Lee, Anu Osinusi, Hepatology	2014	157
BRCA1-associated growth arrest is RB-dependent Olga Aprelikova, Bruno Fang, Eric G. Meissner, Proceedings of the National Academy of Sciences	1999	153
Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study Anita Kohli, A. Osinusi, Zayani Sims, The Lancet HepatologyHepatitis CWeek Triple-drug RegimensViral HepatitisHepatitis B	2015	151
Simtuzumab treatment of advanced liver fibrosis in <scp>HIV</scp> and <scp>HCV</scp>‐infected adults: results of a 6‐month open‐label safety trial Eric G. Meissner, Mary McLaughlin, Ahmed M. Gharib, Liver International	2016	97
IFNL4-ΔG Genotype Is Associated With Slower Viral Clearance in Hepatitis C, Genotype-1 Patients Treated With Sofosbuvir and Ribavirin Eric G. Meissner, Dimitra Bon, Ludmila Prokunina‐Olsson, The Journal of Infectious Diseases	2013	83
V3 Loop Truncations in HIV-1 Envelope Impart Resistance to Coreceptor Inhibitors and Enhanced Sensitivity to Neutralizing Antibodies Meg M. Laakso, Fang-Hua Lee, Beth Haggarty, PLoS Pathogens Genetic TruncationViral ReplicationNeutralizing AntibodiesImmunologyMolecular Biology	2007	75
Re-treatment of Chronic Hepatitis C Virus Genotype 1 Infection After Relapse Anu Osinusi, Anita Kohli, Miriam Marti, Annals of Internal Medicine	2014	73

Page 1